88 related articles for article (PubMed ID: 8611477)
21. A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
Roman-Unfer S; Bitran JD; Garrison L; Proeschel C; Hanauer S; Schroeder L; Johnson L; Klein L; Martinec J
Exp Hematol; 1996 Jun; 24(7):823-8. PubMed ID: 8647233
[TBL] [Abstract][Full Text] [Related]
22. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
23. The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow.
Demuynck H; Pettengell R; de Campos E; Dexter TM; Testa NG
Eur J Cancer; 1992; 28(2-3):381-6. PubMed ID: 1375485
[TBL] [Abstract][Full Text] [Related]
24. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
Gallicchio VS; Hughes NK
Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man.
Socinski MA; Cannistra SA; Elias A; Antman KH; Schnipper L; Griffin JD
Lancet; 1988 May; 1(8596):1194-8. PubMed ID: 2897009
[TBL] [Abstract][Full Text] [Related]
26. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
Ward CS; Westwood NB; Emmerson AJ; Pearson TC
Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
[TBL] [Abstract][Full Text] [Related]
27. CD45 cell surface antigens are linked to stimulation of early human myeloid progenitor cells by interleukin 3 (IL-3), granulocyte/macrophage colony-stimulating factor (GM-CSF), a GM-CSF/IL-3 fusion protein, and mast cell growth factor (a c-kit ligand).
Broxmeyer HE; Lu L; Hangoc G; Cooper S; Hendrie PC; Ledbetter JA; Xiao M; Williams DE; Shen FW
J Exp Med; 1991 Aug; 174(2):447-58. PubMed ID: 1713254
[TBL] [Abstract][Full Text] [Related]
28. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
Vadhan-Raj S; Broxmeyer HE; Andreeff M; Bandres JC; Buescher ES; Benjamin RS; Papadopoulos NE; Burgess A; Patel S; Plager C; Hittelman WN; McAlister I; Garrison L; Williams DE
Blood; 1995 Sep; 86(6):2098-105. PubMed ID: 7662957
[TBL] [Abstract][Full Text] [Related]
29. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
Sieff C; Guinan E
Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
[TBL] [Abstract][Full Text] [Related]
30. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
31. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.
Bhalla K; Ibrado AM; Bradt JE; Ray S; Huang Y; Tang C; Nawabi A; Hoffman R
Leukemia; 1995 Nov; 9(11):1851-6. PubMed ID: 7475274
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
Anderson JE; Appelbaum FR
Curr Opin Hematol; 1994 May; 1(3):203-9. PubMed ID: 9371283
[TBL] [Abstract][Full Text] [Related]
33. Effects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation.
Pettengell R; Luft T; de Wynter E; Coutinho L; Young R; Fitzsimmons L; Scarffe JH; Testa NG
Br J Haematol; 1995 Feb; 89(2):237-42. PubMed ID: 7873372
[TBL] [Abstract][Full Text] [Related]
34. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
Merchav S; Wagemaker G; Souza LM; Tatarsky I
Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
[TBL] [Abstract][Full Text] [Related]
35. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
[TBL] [Abstract][Full Text] [Related]
36. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
37. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
Hintz-Obertreis P; Weinmann E; Seiler FR
Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
[TBL] [Abstract][Full Text] [Related]
38. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
[TBL] [Abstract][Full Text] [Related]
39. The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function.
Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S
Exp Hematol; 1993 Oct; 21(11):1467-72. PubMed ID: 8405227
[TBL] [Abstract][Full Text] [Related]
40. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
